5 found
Order:
Disambiguations
Graham Lindegger [4]Graham Charles Lindegger [1]
  1.  42
    'It Looks Like You Just Want Them When Things Get Rough': Civil Society Perspectives on Negative Trial Results and Stakeholder Engagement in HIV Prevention Trials.Jennifer Koen, Zaynab Essack, Catherine Slack, Graham Lindegger & Peter A. Newman - 2012 - Developing World Bioethics 12 (3):138-148.
    Civil society organizations (CSOs) have significantly impacted on the politics of health research and the field of bioethics. In the global HIV epidemic, CSOs have served a pivotal stakeholder role. The dire need for development of new prevention technologies has raised critical challenges for the ethical engagement of community stakeholders in HIV research. This study explored the perspectives of CSO representatives involved in HIV prevention trials (HPTs) on the impact of premature trial closures on stakeholder engagement. Fourteen respondents from South (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  2.  30
    Stakeholder Perspectives on Ethical Challenges in Hiv Vaccine Trials in South Africa.Zaynab Essack, Jennifer Koen, Nicola Barsdorf, Catherine Slack, Michael Quayle, Cecilia Milford, Graham Lindegger, Chitra Ranchod & Richard Mukuka - 2010 - Developing World Bioethics 10 (1):11-21.
    There is little published literature on the ethical concerns of stakeholders in HIV vaccine trials. This study explored the ethical challenges identified by various stakeholders, through an open-ended, in-depth approach. While the few previous studies have been largely quantitative, respondents in this study had the opportunity to spontaneously identify the issues that they perceived to be of priority concern in the South African context. Stakeholders spontaneously identified the following as ethical priorities: informed consent, social harms, collaborative relationships between research stakeholders, (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  3.  21
    Ensuring Consent to Research is Voluntary: How Far Do We Need to Go?Susan Bull & Graham Charles Lindegger - 2011 - American Journal of Bioethics 11 (8):27-29.
    The American Journal of Bioethics, Volume 11, Issue 8, Page 27-29, August 2011.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  4.  3
    ‘It Looks Like You Just Want Them When Things Get Rough’: Civil Society Perspectives on Negative Trial Results and Stakeholder Engagement in HIV Prevention Trials.Jennifer Koen, Zaynab Essack, Catherine Slack, Graham Lindegger & Peter A. Newman - 2013 - Developing World Bioethics 13 (3):138-148.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  5.  15
    Stakeholder Views of Ethical Guidance Regarding Prevention and Care in HIV Vaccine Trials.Rika Moorhouse, Catherine Slack, Michael Quayle, Zaynab Essack & Graham Lindegger - 2014 - BMC Medical Ethics 15 (1):51.
    South Africa is a major hub of HIV prevention trials, with plans for a licensure trial to start in 2015. The appropriate standards of care and of prevention in HIV vaccine trials are complex and debated issues and ethical guidelines offer some direction. However, there has been limited empirical exploration of South African stakeholders’ perspectives on ethical guidance related to prevention and care in HIV vaccine trials.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark